Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick Amato

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
American Journal of Clinical Pathology|July 20, 2007
Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosisDominick Amato, David G Oscier, Zadie Davis, et al.
Leukemia & Lymphoma|February 28, 2007
Overexpression of SOCS-2 and SOCS-3 genes reverses erythroid overgrowth and IGF-I hypersensitivity of primary polycythemia vera (PV) cellsTatiana Usenko, Denise Eskinazi, Paulo N Correa, et al.
Internal Medicine Journal|August 27, 2024
The natural history of Gaucher disease type 1 in 31 patients over a median of 15 years: a retrospective studySiavash Piran, Graeme A M Nimmo, Amélie Chaboureau, et al.
Orphanet Journal of Rare Diseases|December 29, 2012
Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority studyTimothy M Cox, Dominick Amato, Carla Em Hollak, et al.
Orphanet Journal of Rare Diseases|May 22, 2015
Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Neal J Weinreb, David N Finegold, Eleanor Feingold, et al.
Blood Cells, Molecules & Diseases|June 9, 2009
The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)Ari Zimran, Elizabeth Morris, Eugen Mengel, et al.
Neurology. Genetics|May 21, 2021
Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher DiseaseLais M Oliveira, Tara Rastin, Graeme A M Nimmo, et al.
JAMA|February 18, 2015
Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trialPramod K Mistry, Elena Lukina, Hadhami Ben Turkia, et al.
Blood|September 9, 2011
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher diseaseAri Zimran, Einat Brill-Almon, Raul Chertkoff, et al.
Nature Genetics|August 19, 2003
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)Wei Li, Qing Zhang, Naoki Oiso, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Clinical Pathology|July 20, 2007
Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosisDominick Amato, David G Oscier, Zadie Davis, et al.
Leukemia & Lymphoma|February 28, 2007
Overexpression of SOCS-2 and SOCS-3 genes reverses erythroid overgrowth and IGF-I hypersensitivity of primary polycythemia vera (PV) cellsTatiana Usenko, Denise Eskinazi, Paulo N Correa, et al.
Internal Medicine Journal|August 27, 2024
The natural history of Gaucher disease type 1 in 31 patients over a median of 15 years: a retrospective studySiavash Piran, Graeme A M Nimmo, Amélie Chaboureau, et al.
Orphanet Journal of Rare Diseases|December 29, 2012
Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority studyTimothy M Cox, Dominick Amato, Carla Em Hollak, et al.
Orphanet Journal of Rare Diseases|May 22, 2015
Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Neal J Weinreb, David N Finegold, Eleanor Feingold, et al.
Blood Cells, Molecules & Diseases|June 9, 2009
The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)Ari Zimran, Elizabeth Morris, Eugen Mengel, et al.
Neurology. Genetics|May 21, 2021
Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher DiseaseLais M Oliveira, Tara Rastin, Graeme A M Nimmo, et al.
JAMA|February 18, 2015
Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trialPramod K Mistry, Elena Lukina, Hadhami Ben Turkia, et al.
Blood|September 9, 2011
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher diseaseAri Zimran, Einat Brill-Almon, Raul Chertkoff, et al.
Nature Genetics|August 19, 2003
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)Wei Li, Qing Zhang, Naoki Oiso, et al.
Pageof 3